HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.
about
Phorbol myristate acetate and Bryostatin 1 rescue IFN-gamma inducibility of MHC class II molecules in LS1034 colorectal carcinoma cell lineExpression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype.An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.Prognostic impact of expression of Bcl-2 and Bax genes in circulating immune cells derived from patients with head and neck carcinoma.CD14 and IL18 gene polymorphisms associated with colorectal cancer subsite risks among atomic bomb survivorsMajor histocompatibility antigens and antigen-processing molecules in retinoblastoma.HLA class II antigen expression in conjunctival precancerous lesions and squamous cell carcinomas.Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers.Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue.Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated.
P2860
Q24792961-CBD17B4C-125F-43E3-BCC1-BB5BC7F1537AQ36288263-4D526E0F-FF7F-4A4A-A1C0-09E3794AA1EAQ36431817-508C3639-88BF-4319-AA59-B57BCA3C5B2CQ36670900-DCBD556B-D692-4ADC-9E5B-380C3D5535A0Q36671287-37667C79-7A2C-4653-9EEB-8E31A4679095Q38448761-83BBB49A-CD91-407E-B0BA-124231FCDF7CQ38450471-14E7EB16-91B1-43E8-9359-620A9151D479Q39497597-5C45CA4D-01F3-4296-8032-5350E9C21671Q40011550-CB2509CC-052D-44D4-84B4-5CEC8FE9D38CQ40338058-C1F9479B-A240-4776-836F-7D4BC4F66EA7Q44550678-32ABA5F6-EC89-4B94-85D8-B7AF3E6973DEQ44630353-F268A1E7-852D-4147-9CF1-5C4B9B24C0CE
P2860
HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
HLA-DR antigen expression in c ...... ation with tumour progression.
@ast
HLA-DR antigen expression in c ...... ation with tumour progression.
@en
type
label
HLA-DR antigen expression in c ...... ation with tumour progression.
@ast
HLA-DR antigen expression in c ...... ation with tumour progression.
@en
prefLabel
HLA-DR antigen expression in c ...... ation with tumour progression.
@ast
HLA-DR antigen expression in c ...... ation with tumour progression.
@en
P2093
P2860
P356
P1476
HLA-DR antigen expression in c ...... ation with tumour progression.
@en
P2093
Kobayashi S
Matsushita K
Takenouchi T
P2860
P2888
P304
P356
10.1038/BJC.1996.112
P407
P577
1996-03-01T00:00:00Z